Veterinary Medicines

CANAURAL ausų lašai, suspensija šunims ir katėms

Authorised
  • Nystatin
  • Prednisolone
  • Framycetin sulfate
  • Diethanolamine fusidate
Download as PDF

Product identification

Medicine name:
CANAURAL ausų lašai, suspensija šunims ir katėms
Active substance:
  • Nystatin
  • Prednisolone
  • Framycetin sulfate
  • Diethanolamine fusidate
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
  • Prednisolone
    2.50
    milligram(s)
    /
    1.00
    gram(s)
  • Framycetin sulfate
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • Diethanolamine fusidate
    5.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear drops, suspension
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Veterinary Products A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera Istrazivanja d.o.o.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/97/0539/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 23/11/2022
Download

RV0539.pdf

Lithuanian (PDF)
Published on: 15/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."